Repeated Intravitreal Anti-VEGF Injections May Cause Sustained Elevated IOP | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Friday, August 5, 2011

Email

Comments

Ocular Surgery News

Some patients who received intravitreal anti-VEGF injections showed sustained elevated IOP, a study found.

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us